Literature DB >> 23504318

STAT3-mediated coincidence detection regulates noncanonical immediate early gene induction.

Matthew S Waitkus1, Unni M Chandrasekharan, Belinda Willard, S Jaharul Haque, Paul E DiCorleto.   

Abstract

Signaling pathways interact with one another to form dynamic networks in which the cellular response to one stimulus may depend on the presence, intensity, timing, or localization of other signals. In rare cases, two stimuli may be simultaneously required for cells to elicit a significant biological output. This phenomenon, generally termed "coincidence detection," requires a downstream signaling node that functions as a Boolean AND gate to restrict biological output from a network unless multiple stimuli are received within a specific window of time. Simultaneous activation of the EGF receptor (EGFR) and a thrombin receptor (protease-activated receptor-1, PAR-1) increases the expression of multiple immediate early genes (IEGs) associated with growth and angiogenesis. Using a bioinformatic comparison of IEG promoter regions, we identified STAT3 as a critical transcription factor for the detection of coincident EGFR/PAR-1 activation. EGFR activation induces classical STAT3 Tyr(705) phosphorylation but also initiates an inhibitory signal through the PI3K-AKT signaling axis that prevents STAT3 Ser(727) phosphorylation. Coincident PAR-1 signaling resolves these conflicting EGF-activated pathways by blocking AKT activation and permitting GSK-3α/β-dependent STAT3 Ser(727) phosphorylation and STAT3-dependent gene expression. Functionally, combinatorial EGFR/PAR-1 signaling suppresses EGF-induced proliferation and thrombin-induced leukocyte adhesion and triggers a STAT3-dependent increase in endothelial cell migration. This study reveals a novel signaling role for STAT3 in which the simultaneous presence of extracellular EGF and thrombin is detected at the level of STAT3 post-translational modifications. Collectively, our results describe a novel regulatory mechanism in which combinatorial EGFR/PAR-1 signaling regulates STAT3-dependent IEG induction and endothelial cell migration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23504318      PMCID: PMC3636885          DOI: 10.1074/jbc.M112.428516

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  Dynamic control of signaling by modular adaptor proteins.

Authors:  Tony Pawson
Journal:  Curr Opin Cell Biol       Date:  2007-02-20       Impact factor: 8.382

2.  Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3/4 elements.

Authors:  Wilfried Le Goff; Ping Zheng; Gregory Brubaker; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-22       Impact factor: 8.311

Review 3.  Membrane recognition by phospholipid-binding domains.

Authors:  Mark A Lemmon
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02       Impact factor: 94.444

4.  Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.

Authors:  M Guha; M A O'Connell; R Pawlinski; A Hollis; P McGovern; S F Yan; D Stern; N Mackman
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

5.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

Review 6.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

7.  Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839).

Authors:  Akira Hirata; Hisanori Uehara; Keisuke Izumi; Seiji Naito; Michihiko Kuwano; Mayumi Ono
Journal:  Cancer Sci       Date:  2004-07       Impact factor: 6.716

8.  Thrombin causes increased monocytic-cell adhesion to endothelial cells through a protein kinase C-dependent pathway.

Authors:  P E DiCorleto; C A de la Motte
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

9.  Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas.

Authors:  Cheryl H Baker; Daniel Kedar; Marya F McCarty; Rachel Tsan; Kristen L Weber; Corazon D Bucana; Isaiah J Fidler
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

10.  Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip.

Authors:  Shilpi Arora; Yipeng Wang; Zhenyu Jia; Saynur Vardar-Sengul; Ayla Munawar; Kutbuddin S Doctor; Michael Birrer; Michael McClelland; Eileen Adamson; Dan Mercola
Journal:  Genome Biol       Date:  2008-11-25       Impact factor: 13.583

View more
  7 in total

1.  Signal integration and gene induction by a functionally distinct STAT3 phosphoform.

Authors:  Matthew S Waitkus; Unni M Chandrasekharan; Belinda Willard; Thomas L Tee; Jason K Hsieh; Christopher G Przybycin; Brian I Rini; Paul E Dicorleto
Journal:  Mol Cell Biol       Date:  2014-03-10       Impact factor: 4.272

2.  Vascular Endothelial Cells Produce Coagulation Factors That Control Their Growth via Joint Protease-Activated Receptor and C5a Receptor 1 (CD88) Signaling.

Authors:  Devin Cao; Michael G Strainic; Daniel Counihan; Shiva Sridar; Fengqi An; Wasim Hussain; Alvin H Schmaier; Marvin Nieman; M Edward Medof
Journal:  Am J Pathol       Date:  2022-02       Impact factor: 4.307

3.  Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis.

Authors:  Dong Suwei; Xiao Yanbin; Wang Jianqiang; Ma Xiang; Peng Zhuohui; Kang Jianping; Wang Yunqing; Li Zhen
Journal:  Cell Mol Biol Lett       Date:  2022-06-15       Impact factor: 8.702

4.  Mitogen-activated protein kinase phosphatase-1 promotes neovascularization and angiogenic gene expression.

Authors:  Joel D Boerckel; Unnikrishnan M Chandrasekharan; Matthew S Waitkus; Emily G Tillmaand; Rebecca Bartlett; Paul E Dicorleto
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-27       Impact factor: 8.311

5.  Serine-727 phosphorylation activates hypothalamic STAT-3 independently from tyrosine-705 phosphorylation.

Authors:  Andreas Breit; Valeria Besik; Hans Jürgen Solinski; Susanne Muehlich; Evi Glas; Stephen J Yarwood; Thomas Gudermann
Journal:  Mol Endocrinol       Date:  2015-01-13

6.  Ratios of Four STAT3 Splice Variants in Human Eosinophils and Diffuse Large B Cell Lymphoma Cells.

Authors:  Keren B Turton; Douglas S Annis; Lixin Rui; Stephane Esnault; Deane F Mosher
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

Review 7.  Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment.

Authors:  Moses M Kasembeli; Uddalak Bharadwaj; Prema Robinson; David J Tweardy
Journal:  Int J Mol Sci       Date:  2018-08-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.